Clarifications regarding article in the medical journal Läkemedelsvärlden

In an article published today in the medical journal “Läkemedelsvärlden”, Professor Johnny Ludvigsson is interviewed regarding a trial with Diamyd Medical’s study drug Diamyd® (GAD65). The article deals with an investigator initiated trial, ie, a trial run by a researcher/university which is then the Sponsor of the study. The investigator initiated trial is led by Professor Johnny Ludvigsson at Linköping University. In the trial Diamyd® is tested to be administered into the lymph node. Diamyd Medical's role in the trial is to provide the study drug Diamyd®, safety reporting, and financial